These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8173086)

  • 21. Screening for diabetes: does measurement of serum fructosamine help?
    Swai AB; Harrison K; Chuwa LM; Makene W; McLarty D; Alberti KG
    Diabet Med; 1988 Oct; 5(7):648-52. PubMed ID: 2975548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is examination of fructosamine levels valuable as a diagnostic test for diabetes mellitus?
    Sekikawa A; Tominaga M; Takahashi K; Watanabe H; Miyazawa K; Sasaki H
    Diabetes Res Clin Pract; 1990 Mar; 8(3):187-92. PubMed ID: 2340792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey.
    Nelson KM; Boyko EJ;
    Diabetes Care; 2003 Jul; 26(7):2058-62. PubMed ID: 12832313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of fructosamine in the early diagnosis of disorders of carbohydrate metabolism].
    Gasparian EG; Nersesian SA; Volkova EA; Kriuchkova ZV; Nassur S; Kuz'mina MM
    Probl Endokrinol (Mosk); 1994; 40(6):17-8. PubMed ID: 7740029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preliminary investigation of EZSCAN™ screening for impaired glucose tolerance and diabetes in a patient population.
    Chen X; Chen L; Ding R; Shi Q; Zhang Y; Hu D
    Exp Ther Med; 2015 May; 9(5):1688-1694. PubMed ID: 26136878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiologic concentrations of inorganic phosphate accelerate fructosamine synthesis.
    Kunika K; Yamashita K; Itakura M
    Diabetes Res Clin Pract; 1992 Jul; 17(1):9-16. PubMed ID: 1511664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A formula based on autonomic test using EZSCAN and anthropometric data for diagnosis of DM in China.
    Zhao X; Getmanenko A; Zhang Y; Mo Q; Yao C
    Sci Rep; 2020 Mar; 10(1):4870. PubMed ID: 32184464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of alternative indicators for screening for diabetes mellitus.
    Shirasaya K; Miyakawa M; Yoshida K; Takahashi E; Shimada N; Kondo T
    Prev Med; 1999 Aug; 29(2):79-86. PubMed ID: 10446032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical screening examination for impaired glucose tolerance: is it possible to diagnose impaired glucose tolerance without a 75g oral glucose tolerance test?].
    Igarashi M
    Rinsho Byori; 2012 Apr; 60(4):349-55. PubMed ID: 22686045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detecting impaired glucose tolerance based on medical decision making].
    Takahashi E; Yoshida K; Kondo T
    Nihon Koshu Eisei Zasshi; 1994 Mar; 41(3):237-42. PubMed ID: 8173086
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.